Société DiaMedica Therapeutics Inc.
Actions
DMAC
CA25253X2077
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,5 USD | +16,67% | +35,14% | +23,24% |
Métier
Nombre d'employés: 19
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Rick Pauls
CEO | Chief Executive Officer | 52 | 01/04/05 |
Scott Kellen
DFI | Director of Finance/CFO | 59 | 01/04/18 |
Ambarish Shah
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/23 |
Chief Tech/Sci/R&D Officer | 62 | 22/01 | |
James Parsons
BRD | Director/Board Member | 58 | 20/10/10 |
Paul Papi
IRO | Public Communications Contact | - | 01/12/16 |
Corporate Officer/Principal | - | - | |
Dominic Cundari
PRN | Corporate Officer/Principal | - | 01/02/22 |
David Wambeke
PRN | Corporate Officer/Principal | - | 11/04/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Richard Kuntz
BRD | Director/Board Member | 66 | 30/05/23 |
Tanya Lewis
BRD | Director/Board Member | 53 | 01/03/23 |
James Parsons
BRD | Director/Board Member | 58 | 20/10/10 |
Michael Giuffre
BRD | Director/Board Member | 68 | 10/08/10 |
Rick Pauls
CEO | Chief Executive Officer | 52 | 01/04/05 |
Richard Pilnik
CHM | Chairman | 67 | 01/05/09 |
Charles Semba
BRD | Director/Board Member | 64 | 15/07/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 37 958 000 | 23 517 237 ( 61,96 %) | 0 | 61,96 % |
Coordonnées société
DiaMedica Therapeutics, Inc.
301 Carlson Parkway Suite 210
55305, Minneapolis
+
http://www.diamedica.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+23,24% | 114 M | |
+9,15% | 105 Md | |
-1,08% | 104 Md | |
+5,79% | 22,94 Md | |
-11,55% | 22,34 Md | |
-7,01% | 19,25 Md | |
-37,08% | 17,08 Md | |
-9,91% | 16,96 Md | |
+7,55% | 14,16 Md | |
+40,04% | 12,63 Md |
- Bourse
- Actions
- Action DMAC
- Société DiaMedica Therapeutics Inc.